InMode (INMD) Current Deferred Revenue (2018 - 2026)
InMode (INMD) posted quarterly Current Deferred Revenue of $16.4 million for Q1 2026, up 3.2% year-on-year from $15.9 million in Q1 2025, and up 35.36% on a QoQ basis from $12.1 million in Q4 2025.
InMode (INMD) Current Deferred Revenue (2018 - 2026) Analysis & Trends
InMode (INMD) has reported Current Deferred Revenue for 9 consecutive years, with $16.4 million the latest figure, recorded in Q1 2026.
- Quarterly Current Deferred Revenue rose 3.2% year-over-year to $16.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.4 million (up 3.2% YoY) and the FY2025 annual result came in at $12.1 million, down 27.82% from the prior year.
- Current Deferred Revenue advanced to $16.4 million in Q1 2026 per INMD's latest filing, from $12.1 million in the prior quarter.
- Over the last five years, Current Deferred Revenue for INMD reached as high as $43.6 million in Q2 2024 and fell as low as $10.6 million in Q3 2023.
- A 5-year average of $16.5 million and a median of $15.9 million in 2025 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2024 — Current Deferred Revenue jumped 292.95% — and 2025, when it slumped 70.2%.
- Year by year, Current Deferred Revenue stood at $13.8 million in 2022, then fell by 20.84% to $10.9 million in 2023, then surged by 53.39% to $16.8 million in 2024, then fell by 27.82% to $12.1 million in 2025, then surged by 35.36% to $16.4 million in 2026.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $16.4 million, $12.1 million, and $15.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | InMode | 956,721.10 | -479.17 Mn | 61.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.37 Mn |
| Dec 31, 2025 | 12.09 Mn |
| Sep 30, 2025 | 15.10 Mn |
| Jun 30, 2025 | 13.00 Mn |
| Mar 31, 2025 | 15.86 Mn |
| Dec 31, 2024 | 16.76 Mn |
| Sep 30, 2024 | 17.23 Mn |
| Jun 30, 2024 | 43.61 Mn |
| Mar 31, 2024 | 20.52 Mn |
| Dec 31, 2023 | 10.92 Mn |
| Sep 30, 2023 | 10.63 Mn |
| Jun 30, 2023 | 11.10 Mn |
| Mar 31, 2023 | 17.29 Mn |
| Dec 31, 2022 | 13.80 Mn |
| Sep 30, 2022 | 12.45 Mn |
| Jun 30, 2022 | 18.10 Mn |
| Mar 31, 2022 | 16.33 Mn |
| Dec 31, 2021 | 16.56 Mn |
| Sep 30, 2021 | 12.80 Mn |
| Jun 30, 2021 | 13.33 Mn |